This inventor holds 2 USPTO granted patents. Top assignees: Ares Trading S.a., Merck Serono S. a.. Active years: 2015.
Location History:
- Nyon, CH (2015)
- Geneva, CH (2015)
Company Filing History:
Years Active: 2015
Title: The Innovations of Clement Olivier
Introduction
Clement Olivier is a notable inventor based in Nyon, Switzerland. He has made significant contributions to the field of genetics, particularly in the area of growth hormone therapy. With a total of 2 patents, Olivier's work has the potential to impact the treatment of patients with Growth Hormone Deficiency (GHD) and Turner Syndrome (TS).
Latest Patents
Olivier's latest patents focus on genomic markers for predicting the long-term response to growth hormone therapy. The first patent relates to the use of genetic markers to identify the response to growth hormone treatment in patients suffering from GHD or TS. This invention also includes a method for treating these patients and kits for genotyping. The second patent mirrors the first, emphasizing the importance of genetic markers in determining treatment efficacy.
Career Highlights
Throughout his career, Clement Olivier has worked with reputable companies such as Ares Trading S.A. and Merck Serono S.A. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of genetics and therapy.
Collaborations
Olivier has collaborated with professionals like Pascal Croteau and John Raelson, contributing to the advancement of his research and inventions.
Conclusion
Clement Olivier's work in the field of genetic markers and growth hormone therapy showcases his dedication to improving patient outcomes. His patents reflect a commitment to innovation that could change the landscape of treatment for GHD and TS patients.